Linkage Global Inc

Linkage Global Inc (UZX) Stock Analysis

$1.010

0.000 (0.00%)At close

Loading chart…
High
1.020
Open
1.000
VWAP
1.01
Volume
17.12K
Mkt Cap
—
Low
1.000
Amount
17.29K
EV/EBITDA, TTM
0.00

Linkage Global Inc is a Japan-based company mainly engaged in the provision of cross-border e-commerce integrated services. The Company is engaged in the development of a comprehensive service system comprised of two lines of business complementary to each other, including cross-border sales and integrated e-commerce services. Cross-border sales business is engaged in the import and export sales of products are sourced from Japanese and Chinese manufacturers and brands, and private label smart products. The main products include pharmaceuticals, cosmetics, detergents, sanitary products, daily necessities, foodstuffs, alcoholic beverages, miscellaneous goods, household electrical appliances and others. Integrated e-commerce business is engaged in the provision of digital marketing services to the merchants through connecting the merchants with social media platforms.

AI analysis of Linkage Global Inc (UZX)

Hold

Linkage Global Inc (UZX) is currently not a strong buy due to its significant price decline of 89.34% year-to-date and a low RSI of 37.774, indicating potential oversold conditions. The stock is trading at $1.01, which is near its 52-week low of $0.75, and it has received a Nasdaq warning for trading below $1 for over 30 days, posing a risk of delisting. While the recent approval of an $8 million share buyback program could provide some support, the company's net loss of $1.67 million in the first half of 2025 and a 25.1% decline in revenue raise concerns about its financial health. Therefore, it is advisable to hold off on buying until there are clearer signs of recovery and compliance with Nasdaq requirements.

Valuation Metrics

The current forward P/E ratio for Linkage Global Inc (UZX) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Events Timeline

2026-09-29 (ET)

17:00:00

Linkage Global Terminates $20M Investment Agreement with Capital Finance

2026-09-18 (ET)

20:00:00

Linkage Global Inc Trading Halted, News Pending

2026-09-17 (ET)

07:00:00

Linkage Global Shareholders Approve 23-for-1 Share Consolidation

2026-09-14 (ET)

08:30:00

Linkage Global Signs Strategic Investment Agreement with Capital Finance for $20M

2026-08-11 (ET)

06:30:00

Linkage Global Explores Opportunities in Hospitality Industry

News

UZX FAQ — answered by Alphio AI

Linkage Global Inc is a Japan-based company mainly engaged in the provision of cross-border e-commerce integrated services. The Company is engaged in the development of a comprehensive service system comprised of two lines of business complementary to each other, including cross-border sales and integrated e-commerce services. Cross-border sales business is engaged in the import and export sales of products are sourced from Japanese and Chinese manufacturers and brands, and private label smart products. The main products include pharmaceuticals, cosmetics, detergents, sanitary products, daily necessities, foodstuffs, alcoholic beverages, miscellaneous goods, household electrical appliances and others. Integrated e-commerce business is engaged in the provision of digital marketing services to the merchants through connecting the merchants with social media platforms. It operates in the Consumer Cyclicals sector.

Linkage Global Inc (UZX) is currently not a strong buy due to its significant price decline of 89.34% year-to-date and a low RSI of 37.774, indicating potential oversold conditions. The stock is trading at $1.01, which is near its 52-week low of $0.75, and it has received a Nasdaq warning for trading below $1 for over 30 days, posing a risk of delisting. While the recent approval of an $8 million share buyback program could provide some support, the company's net loss of $1.67 million in the first half of 2025 and a 25.1% decline in revenue raise concerns about its financial health. Therefore, it is advisable to hold off on buying until there are clearer signs of recovery and compliance with Nasdaq requirements.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading